Across TCGA pan-cancer cohorts, TMSB4XP3 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated TMSB4XP3 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TMSB4XP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TMSB4XP3 expression acts as an unfavorable survival marker, although some lineages such as OV and READ show a favorable association.
UCEC, KIRP, and COAD are the cancer types where TMSB4XP3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.